Urology Week 2024, which closes out The Urology Foundation’s Urology Awareness Month, is a good time to highlight the innovations in this space. This week (Sept. 23-29), is an initiative of the European Association of Urology that brings together national urological societies, urology practitioners, urology nurses, patients and their families, and politicians to create awareness of urological […]
affluentmedical
Affluent Medical signs $16.3M mitral valve deals with Edwards
Affluent Medical announced today that it entered into a number of agreements with Edwards Lifesciences related to structural heart products. The deals cover Affluent’s Kalios adjustable mitral annulus and mitral valve technology. Under the terms of the agreements, Affluent receives $16.3 million (€15 million) upfront as a cash payment. Edwards agreed to pay $5.44 million […]
Affluent Medical touts first implant of artificial urinary sphincter
Affluent Medical today announced the successful first-in-human implant of its minimally invasive urinary incontinence treatment device. Dr. Roman Zachoval completed the first implant of Artus, an artificial urinary sphincter. Zachoval, head of urology at Thomayer University Hospital in Prague, implanted Artus in a 68-year-old male patient with severe urinary incontinence. The procedure lasted about 80 […]
Affluent Medical has positive biomimetic mitral valve data
Affluent Medical today announced positive findings in a clinical evaluation of its Epygon device for replacing mitral valves. The Aix-en-Provence, France-based company designed Epygon to replace mitral valves in those with mitral insufficiency. Epygon is the first biomimetic transcatheter mitral valve to mimic the native mitral valve and restore the natural vortex of blood flow […]
Affluent Medical touts results of endovascular aneurysm repair study
Medtech startup Affluent Medical (Paris, France) said a study of its endovascular aneurysm repair (EVAR) system device showed patients had fewer endoleaks and needed fewer secondary interventions, and that their aneurysms shrank in volume and diameter. The company’s Kardiozis endovascular prosthesis uses thrombogenic fibers to embolize an abdominal aortic aneurism sac during a conventional EVAR procedure […]
